Picture of Tianjin Development Holdings logo

882 — Tianjin Development Holdings News Story

0.000.00%
hk flag iconLast trade - 00:00
UtilitiesConservativeSmall CapNeutral

Brief: Tianjin Development Says FY Net Profit Attributable Of Tianjin Lisheng Pharmaceutical Is RMB8.6 Million

March 24 (Reuters) - Tianjin Lisheng Pharmaceutical Co Ltd
 002393.SZ :
    * FY NET PROFIT ATTRIBUTABLE OF TIANJIN LISHENG
PHARMACEUTICAL
RMB8.6 MILLION VERSUS RMB188.1 MILLION
    * FY TOTAL OPERATING INCOME FOR TIANJIN LISHENG
PHARMACEUTICAL
RMB1.14 BILLION VERSUS RMB1.62 BILLION
    * LISHENG  PHARMACEUTICAL PROPOSED CASH DIVIDEND OF RMB1.00
(TAX
INCLUSIVE) FOR EVERY  10 SHARES

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS6TvBFX
Further company coverage:  002393.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Tianjin Development Holdings

See all news